ヘリコバクターピロリ菌診断市場：検査タイプ別、方法別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

Allied Market Researchが発行した調査レポートによると、ヘリコバクターピロリ菌診断市場は2022年に5億5,265万米ドルと評価され、2023年から2032年にかけてCAGR 5.3%で成長し、2032年には9億2,680万米ドルに達すると予測されています。

ヘリコバクターピロリ菌診断市場は、ピロリ菌検査機器の需要減少により、ロックダウン期間にマイナスの影響を受けました。また、感染への恐怖から医療施設を訪れる患者が減少したため、ピロリ菌検査を受ける患者数が減少し、市場成長にマイナスの影響を与えました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場の定義と範囲
• 主な調査結果
  • 影響要因
  • 主な投資機会
• ポーターのファイブフォース分析
  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競合の激しさ
• 市場力学
  • 促進要因
    • 感染症の流行
    • 非侵襲的診断法に対する需要の増加
    • 新しく改良された検査法の開発
  • 抑制要因
    • 認識不足と熟練専門家の不足
  • 機会
    • ポイントオブケアでのピロリ菌検査需要の増加
• COVID-19：市場への影響分析

第4章 ヘリコバクターピロリ菌診断市場：検査タイプ別

• 概要
• 非侵襲的検査
• 侵襲的検査

第5章 ヘリコバクターピロリ菌診断市場：方法別

• 概要
• ラボベース検査
• ポイントオブケア検査

第6章 ヘリコバクターピロリ菌診断市場：エンドユーザー別

• 概要
• 病院
• 診断研究所
• その他

第7章 ヘリコバクターピロリ菌診断市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ブラジル
  • サウジアラビア
  • 南アフリカ
  • その他の地域

第8章 競合情勢

• イントロダクション
• 主要成功戦略
• 主要10企業の製品マッピング
• 競合ダッシュボード
• 競合ヒートマップ
• 主要企業のポジショニング、2022年

第9章 企業プロファイル

• Thermo Fisher Scientific Inc.
• Meridian Bioscience, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Cardinal Health Inc.
• Avanos Medical, Inc.
• Gulf Coast Scientific
• Quidel Corporation
• Biohit Oyj

LIST OF TABLES

• TABLE 01. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 02. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR NON-INVASIVE TEST, BY REGION, 2022-2032 ($MILLION)
• TABLE 03. GLOBAL NON-INVASIVE TEST HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TYPE, 2022-2032 ($MILLION)
• TABLE 04. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR INVASIVE TEST, BY REGION, 2022-2032 ($MILLION)
• TABLE 05. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 06. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR LABORATORY BASED TEST, BY REGION, 2022-2032 ($MILLION)
• TABLE 07. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR POINT OF CARE TEST, BY REGION, 2022-2032 ($MILLION)
• TABLE 08. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 09. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
• TABLE 10. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR DIAGNOSTICS LABORATORIES, BY REGION, 2022-2032 ($MILLION)
• TABLE 11. HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 12. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY REGION, 2022-2032 ($MILLION)
• TABLE 13. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 14. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 15. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 16. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 17. U.S. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 18. U.S. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 19. U.S. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 20. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 21. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 22. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 23. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 24. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 25. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 26. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 27. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 28. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 29. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 30. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 31. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 32. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 33. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 34. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 35. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 36. UK HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 37. UK HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 38. UK HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 39. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 40. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 41. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 42. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 43. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 44. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 45. REST OF EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 46. REST OF EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 47. REST OF EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 48. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 49. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 50. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 51. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 52. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 53. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 54. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 55. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 56. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 57. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 58. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 59. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 60. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 61. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 62. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 63. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 64. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 65. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 66. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 67. REST OF ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 68. REST OF ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 69. REST OF ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 70. LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 71. LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 72. LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 73. LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 74. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 75. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 76. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 77. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 78. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 79. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 80. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 81. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 82. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 83. REST OF LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
• TABLE 84. REST OF LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022-2032 ($MILLION)
• TABLE 85. REST OF LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 86. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
• TABLE 87. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
• TABLE 88. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
• TABLE 89. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
• TABLE 90. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
• TABLE 91. MERIDIAN BIOSCIENCE, INC.: KEY EXECUTIVES
• TABLE 92. MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT
• TABLE 93. MERIDIAN BIOSCIENCE, INC.: PRODUCT SEGMENTS
• TABLE 94. MERIDIAN BIOSCIENCE, INC.: PRODUCT PORTFOLIO
• TABLE 95. MERIDIAN BIOSCIENCE, INC.: KEY STRATERGIES
• TABLE 96. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
• TABLE 97. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
• TABLE 98. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
• TABLE 99. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
• TABLE 100. ABBOTT LABORATORIES: KEY EXECUTIVES
• TABLE 101. ABBOTT LABORATORIES: COMPANY SNAPSHOT
• TABLE 102. ABBOTT LABORATORIES: PRODUCT SEGMENTS
• TABLE 103. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
• TABLE 104. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
• TABLE 105. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
• TABLE 106. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
• TABLE 107. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
• TABLE 108. CARDINAL HEALTH INC.: KEY EXECUTIVES
• TABLE 109. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
• TABLE 110. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
• TABLE 111. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
• TABLE 112. AVANOS MEDICAL, INC.: KEY EXECUTIVES
• TABLE 113. AVANOS MEDICAL, INC.: COMPANY SNAPSHOT
• TABLE 114. AVANOS MEDICAL, INC.: PRODUCT SEGMENTS
• TABLE 115. AVANOS MEDICAL, INC.: PRODUCT PORTFOLIO
• TABLE 116. GULF COAST SCIENTIFIC: KEY EXECUTIVES
• TABLE 117. GULF COAST SCIENTIFIC: COMPANY SNAPSHOT
• TABLE 118. GULF COAST SCIENTIFIC: PRODUCT SEGMENTS
• TABLE 119. GULF COAST SCIENTIFIC: PRODUCT PORTFOLIO
• TABLE 120. QUIDEL CORPORATION: KEY EXECUTIVES
• TABLE 121. QUIDEL CORPORATION: COMPANY SNAPSHOT
• TABLE 122. QUIDEL CORPORATION: PRODUCT SEGMENTS
• TABLE 123. QUIDEL CORPORATION: PRODUCT PORTFOLIO
• TABLE 124. BIOHIT OYJ: KEY EXECUTIVES
• TABLE 125. BIOHIT OYJ: COMPANY SNAPSHOT
• TABLE 126. BIOHIT OYJ: PRODUCT SEGMENTS
• TABLE 127. BIOHIT OYJ: PRODUCT PORTFOLIO
• TABLE 128. BIOHIT OYJ: KEY STRATERGIES

LIST OF FIGURES

• FIGURE 01. HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032
• FIGURE 02. SEGMENTATION OF HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032
• FIGURE 03. TOP INVESTMENT POCKETS IN HELICOBACTER PYLORI DIAGNOSTICS MARKET (2023-2032)
• FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
• FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
• FIGURE 06. MODERATE THREAT OF SUBSTITUTES
• FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
• FIGURE 08. MODERATE INTENSITY OF RIVALRY
• FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALHELICOBACTER PYLORI DIAGNOSTICS MARKET
• FIGURE 10. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE, 2022(%)
• FIGURE 11. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR NON-INVASIVE TEST, BY COUNTRY 2022 AND 2032(%)
• FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR INVASIVE TEST, BY COUNTRY 2022 AND 2032(%)
• FIGURE 13. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD, 2022(%)
• FIGURE 14. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR LABORATORY BASED TEST, BY COUNTRY 2022 AND 2032(%)
• FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR POINT OF CARE TEST, BY COUNTRY 2022 AND 2032(%)
• FIGURE 16. HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER, 2022(%)
• FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR DIAGNOSTICS LABORATORIES, BY COUNTRY 2022 AND 2032(%)
• FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HELICOBACTER PYLORI DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 20. HELICOBACTER PYLORI DIAGNOSTICS MARKET BY REGION, 2022
• FIGURE 21. U.S. HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 22. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 23. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 24. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 25. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 26. UK HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 27. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 28. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 29. REST OF EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 30. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 31. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 32. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 33. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 34. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 35. REST OF ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 36. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 37. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 38. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 39. REST OF LAMEA HELICOBACTER PYLORI DIAGNOSTICS MARKET, 2022-2032 ($MILLION)
• FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
• FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
• FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
• FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 44. COMPETITIVE DASHBOARD
• FIGURE 45. COMPETITIVE HEATMAP: HELICOBACTER PYLORI DIAGNOSTICS MARKET
• FIGURE 46. TOP PLAYER POSITIONING, 2022
• FIGURE 47. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 48. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 49. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 50. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
• FIGURE 51. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 52. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
• FIGURE 54. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 56. F. HOFFMANN-LA ROCHE LTD.: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 57. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 58. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 59. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 60. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 61. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 62. AVANOS MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
• FIGURE 63. AVANOS MEDICAL, INC.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 64. QUIDEL CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
• FIGURE 65. QUIDEL CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
• FIGURE 66. QUIDEL CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
• FIGURE 67. BIOHIT OYJ: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 68. BIOHIT OYJ: REVENUE SHARE BY REGION, 2022 (%)

According to a new report published by Allied Market Research, titled, "Helicobacter Pylori Diagnostics Market," The helicobacter pylori diagnostics market was valued at $552.65 million in 2022, and is estimated to reach $926.8 million by 2032, growing at a CAGR of 5.3% from 2023 to 2032.

The helicobacter pylori diagnostics market was negatively impacted during the lockdown period owing to decrease in demand for H. pylori testing devices. In addition, decrease in patient visits to healthcare facilities due to fear of infection led to reduce the number of patients undergoing H. pylori testing, which negatively impacted the market growth.

Market Dynamics

H. pylori infection is a major risk factor for gastric cancer. Increase in the incidence of gastric cancer there is a growing demand for early detection and treatment of H. pylori infections that propels helicobacter pylori diagnostics market growth. For instance, American Cancer Society's estimated for stomach cancer (also known as gastric cancer) in the U.S. 2023. Thus, the rise in cases of gastric cancer drives the demand for H. pylori diagnostic testing and further propels market growth.

In addition, growing demand for non-invasive tests boosts market growth. Patients prefer non-invasive diagnostic tests such as breath tests and stool antigen tests over invasive tests such as endoscopy. Thus, demand for non-invasive tests has driven the development of new diagnostic technologies which further fuel the growth during helicobacter pylori diagnostics market forecast.

The growth of the helicobacter pylori diagnostics market is expected to be driven by high potential in untapped, emerging markets, due to availability of improved healthcare infrastructure, increase in unmet healthcare needs, and rise in prevalence of infectious diseases.

Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare services, significant investments by government to improve healthcare infrastructure, and development of the medical tourism industry in emerging countries.

Moreover, early diagnosis and treatment of H. pylori infections can help to prevent the development of more serious complications, such as gastric cancer that supports market growth. As a result, there is an increase in demand for H. pylori testing to facilitate early detection and treatment. H. pylori infections are associated with several gastrointestinal diseases, including peptic ulcer disease and gastric cancer. Thus, a rise in awareness of these diseases led to an increase in the demand for H. pylori testing and further boost the grwoth of the helicobacter pylori diagnostics market size.

The demand for helicobacter pylori diagnostics is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the market. Factors such as rise in adoption of point of care testing, and increase in awareness toward early diagnosis, further drive the growth of the market.

Lack of awareness about the H. pylori infection among the general population is a restraining factor for the growth of the H. pylori diagnostics market. Many people are not aware of the symptoms and complications associated with H. pylori infection, which leads to delayed diagnosis and treatment. Regulatory issues related to the approval of new diagnostic tests for H. pylori may also act as a restraining factor for market growth. The regulatory approval process is time-consuming and expensive, which may limit the availability of new and innovative H. pylori diagnostics tests in the market.

The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The global helicobacter pylori diagnostics industry experienced a decline in 2021 due to global economic recession led by COVID-19. The COVID-19 pandemic has led to the postponement or cancellation of non-urgent diagnostic procedures, including H. pylori testing. This has resulted in a decline in the demand for H. pylori testing, which has affected the revenue of companies operating in this market. In addition, pandemic also led to a decrease in patient visits to healthcare facilities due to fear of infection and the implementation of social distancing measures. This reduced the number of patients undergoing H. pylori testing, which impacted the market negatively.

However, the market is recovering after 2022, and show stable growth for the Helicobacter pylori diagnostics market in the coming future. This is attributed to the development of innovative and cost-effective diagnostic technologies and the availability of effective treatment options for H. pylori infection are expected to drive the growth of the H. pylori diagnostics market in the coming years.

Segmental Overview

The helicobacter pylori diagnostics market is segmented into test type, method, end user, and region. By test type, the market is categorized into non-invasive test and invasive test. The non-invasive test segment is further divided into the serology test, stool antigen test, and carbon urea breath test. On the basis of method, the market is segregated into laboratory-based test and point of care test. By end user, the market is classified into hospitals, diagnostic laboratories, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits For Stakeholders:

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the helicobacter pylori diagnostics market analysis from 2022 to 2032 to identify the prevailing helicobacter pylori diagnostics market opportunity.

• The market research is offered along with information related to key drivers, restraints, and opportunities.

• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

• In-depth analysis of the helicobacter pylori diagnostics market segmentation assists to determine the prevailing market opportunities.

• Major countries in each region are mapped according to their revenue contribution to the global market.

• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

• The report includes the analysis of the regional as well as global helicobacter pylori diagnostics market trends, key players, market segments, application areas, and market growth strategies.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Bargaining power of suppliers
  • 3.3.2. Bargaining power of buyers
  • 3.3.3. Threat of substitutes
  • 3.3.4. Threat of new entrants
  • 3.3.5. Intensity of rivalry
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in prevalence of infectious diseases
    • 3.4.1.2. Increase in demand for non-invasive diagnostic procedures
    • 3.4.1.3. Development of new and improved testing methods

• 3.4.2. Restraints
  • 3.4.2.1. Lack of awareness and shortage of skilled professionals

• 3.4.3. Opportunities
  • 3.4.3.1. Rise in demand for point of care H. pylori testing

• 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY TEST TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Non-Invasive Test
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. Non-Invasive Test Helicobacter Pylori Diagnostics Market by Type
• 4.3. Invasive Test
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY METHOD

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Laboratory Based Test
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Point of Care Test
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country

CHAPTER 6: HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Diagnostics Laboratories
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: HELICOBACTER PYLORI DIAGNOSTICS MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key trends and opportunities
  • 7.2.2. Market size and forecast, by Test Type
  • 7.2.3. Market size and forecast, by Method
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Key market trends, growth factors and opportunities
    • 7.2.5.1.2. Market size and forecast, by Test Type
    • 7.2.5.1.3. Market size and forecast, by Method
    • 7.2.5.1.4. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Key market trends, growth factors and opportunities
    • 7.2.5.2.2. Market size and forecast, by Test Type
    • 7.2.5.2.3. Market size and forecast, by Method
    • 7.2.5.2.4. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Key market trends, growth factors and opportunities
    • 7.2.5.3.2. Market size and forecast, by Test Type
    • 7.2.5.3.3. Market size and forecast, by Method
    • 7.2.5.3.4. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key trends and opportunities
  • 7.3.2. Market size and forecast, by Test Type
  • 7.3.3. Market size and forecast, by Method
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Key market trends, growth factors and opportunities
    • 7.3.5.1.2. Market size and forecast, by Test Type
    • 7.3.5.1.3. Market size and forecast, by Method
    • 7.3.5.1.4. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Key market trends, growth factors and opportunities
    • 7.3.5.2.2. Market size and forecast, by Test Type
    • 7.3.5.2.3. Market size and forecast, by Method
    • 7.3.5.2.4. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Key market trends, growth factors and opportunities
    • 7.3.5.3.2. Market size and forecast, by Test Type
    • 7.3.5.3.3. Market size and forecast, by Method
    • 7.3.5.3.4. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Key market trends, growth factors and opportunities
    • 7.3.5.4.2. Market size and forecast, by Test Type
    • 7.3.5.4.3. Market size and forecast, by Method
    • 7.3.5.4.4. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Key market trends, growth factors and opportunities
    • 7.3.5.5.2. Market size and forecast, by Test Type
    • 7.3.5.5.3. Market size and forecast, by Method
    • 7.3.5.5.4. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Key market trends, growth factors and opportunities
    • 7.3.5.6.2. Market size and forecast, by Test Type
    • 7.3.5.6.3. Market size and forecast, by Method
    • 7.3.5.6.4. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key trends and opportunities
  • 7.4.2. Market size and forecast, by Test Type
  • 7.4.3. Market size and forecast, by Method
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Key market trends, growth factors and opportunities
    • 7.4.5.1.2. Market size and forecast, by Test Type
    • 7.4.5.1.3. Market size and forecast, by Method
    • 7.4.5.1.4. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Key market trends, growth factors and opportunities
    • 7.4.5.2.2. Market size and forecast, by Test Type
    • 7.4.5.2.3. Market size and forecast, by Method
    • 7.4.5.2.4. Market size and forecast, by End User
    • 7.4.5.3. India
    • 7.4.5.3.1. Key market trends, growth factors and opportunities
    • 7.4.5.3.2. Market size and forecast, by Test Type
    • 7.4.5.3.3. Market size and forecast, by Method
    • 7.4.5.3.4. Market size and forecast, by End User
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Key market trends, growth factors and opportunities
    • 7.4.5.4.2. Market size and forecast, by Test Type
    • 7.4.5.4.3. Market size and forecast, by Method
    • 7.4.5.4.4. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Key market trends, growth factors and opportunities
    • 7.4.5.5.2. Market size and forecast, by Test Type
    • 7.4.5.5.3. Market size and forecast, by Method
    • 7.4.5.5.4. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Key market trends, growth factors and opportunities
    • 7.4.5.6.2. Market size and forecast, by Test Type
    • 7.4.5.6.3. Market size and forecast, by Method
    • 7.4.5.6.4. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key trends and opportunities
  • 7.5.2. Market size and forecast, by Test Type
  • 7.5.3. Market size and forecast, by Method
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Key market trends, growth factors and opportunities
    • 7.5.5.1.2. Market size and forecast, by Test Type
    • 7.5.5.1.3. Market size and forecast, by Method
    • 7.5.5.1.4. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Key market trends, growth factors and opportunities
    • 7.5.5.2.2. Market size and forecast, by Test Type
    • 7.5.5.2.3. Market size and forecast, by Method
    • 7.5.5.2.4. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Key market trends, growth factors and opportunities
    • 7.5.5.3.2. Market size and forecast, by Test Type
    • 7.5.5.3.3. Market size and forecast, by Method
    • 7.5.5.3.4. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Key market trends, growth factors and opportunities
    • 7.5.5.4.2. Market size and forecast, by Test Type
    • 7.5.5.4.3. Market size and forecast, by Method
    • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Thermo Fisher Scientific Inc.
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
• 9.2. Meridian Bioscience, Inc.
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Key strategic moves and developments
• 9.3. Bio-Rad Laboratories, Inc.
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
• 9.4. Abbott Laboratories
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. F. Hoffmann-La Roche Ltd.
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
• 9.6. Cardinal Health Inc.
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Business performance
• 9.7. Avanos Medical, Inc.
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
• 9.8. Gulf Coast Scientific
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
• 9.9. Quidel Corporation
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
• 9.10. Biohit Oyj
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance
  • 9.10.7. Key strategic moves and developments